Replicate design(s): why not? [Regulatives / Guidelines]

posted by luvblooms  – India, 2011-04-05 10:54 (5565 d 19:13 ago) – Posting: # 6858
Views: 4,247

Dear HS and Other members

Regards
:flower:

❝ Why not? Reading in between


Yes!!
This is what gave us hope!
Besides there was a paper published in 2003 Discussion Paper
Bioequivalence Requirements: Highly Variable Drugs and Highly Variable Drug Products: Issues and Options
where they have discussed about SABE and RABE. But they didn't fail to mention that THESE PAPERS ARE INTENDED ONLY FOR DISCUSSION AT THE WORKSHOP AND EAC-BB MEETING ON JUNE 26-27, 2003

We are planning to submit the study with an ammendment in protocol!!
Lets see!!

Will update to the forum if anything interesting comes up!!


Besides
There was one more observation in one of the study for Canada Market
Out of 72 volunteer 2 showed 0 absorption for reference!!!
Looks like buggers :angry: threw the formulations away!!

Though the study is passing with and without those volunteers and we have decided to submit the same to the Health Canada.

But I would like to ask that in such condition, how one should handle it?
Any suggestion??:confused:

Thanks in advance!!

Luv

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
299 visitors (0 registered, 299 guests [including 15 identified bots]).
Forum time: 06:07 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5